Now that the longest government shutdown in history has concluded, the SEC is poised to resume regular operations. Three deals are on the calendar for the week ahead.
OTC-listed bank Central Bancompany (CBC) plans to raise $400 million at a $5.4 billion market cap. Central is a super-community bank with 156 full-service branches across 17 MSAs, with business predominantly located in Missouri, though it is growing its presence in the states of Kansas, Oklahoma, Colorado, and Florida. The bank’s cost of deposits is relatively low, allowing it to generate a strong net interest margin, though asset growth has been minimal, up just 1% in 2024.
Faith-focused technology platform Gloo Holdings (GLOO) plans to raise $100 million at an $801 million market cap. The company provides a vertical platform to faith-based organizations, with an emphasis on churches and Christian organizations, serving approximately 57,000 paying customers as of July 31, 2025. Gloo operates in a unique market, and while it has demonstrated strong growth, it has relied heavily on acquisitions as a driver.
Israeli regenerative medicine company Regentis Biomaterials (RGNT) is tentatively scheduled to raise $11 million at a $62 million market cap. Its lead candidate is GelrinC, a cell-free, off-the-shelf hydrogel implant for painful injuries to articular knee cartilage. GelrinC was approved as a device in Europe in 2017, and the company is currently carrying out a pivotal trial for pre-marketing approval in the US.
| U.S. IPO Calendar | |||
|---|---|---|---|
| Issuer Business | Deal Size Market Cap | Price Range Shares Filed | Top Bookrunners |
| Gloo Holdings (GLOO) Boulder, CO | $100M $801M | $10 - $12 9,100,000 | Roth Cap. |
| Provides digital tools and services and an online store for Christian organizations. | |||
| Central Bancompany (CBC) Jefferson City, MO | $400M $5,365M | $21 - $24 17,778,000 | Morgan Stanley KBW |
| Missouri-based bank with 156 locations across five states. | |||
| Regentis Biomaterials (RGNT) Herzliya, Israel | $11M $62M | $10 - $12 1,000,000 | ThinkEquity |
| Israeli regenerative medicine company developing orthopedic hydrogel implants. | |||
Street research is expected for five companies in the week ahead, and five lock-up periods will be expiring. For access to Street research and lock-up expiration dates, sign up for a free trial of IPO Pro.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/13/2025, the Renaissance IPO Index was up 1.8% year-to-date, while the S&P 500 was up 15.8%. Renaissance Capital’s IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Kenvue (KVUE) and Arm Holdings (ARM). The Renaissance International IPO Index was up 41.8% year-to-date, while the ACWX was up 31.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Galderma and Horizon Robotics.
